-
Something wrong with this record ?
Synthesis, Antimalarial, Antileishmanial, and Cytotoxicity Activities and Preliminary In Silico ADMET Studies of 2-(7-Chloroquinolin-4-ylamino)ethyl Benzoate Derivatives
JE. Gutiérrez, H. Ramírez, E. Fernandez-Moreira, ME. Acosta, MR. Mijares, JB. De Sanctis, S. Gurská, P. Džubák, M. Hajdúch, L. Labrador-Fagúndez, BG. Stella, LJ. Díaz-Pérez, G. Benaim, JE. Charris
Status not-indexed Language English Country Switzerland
Document type Journal Article
Grant support
028/2022, 055/2023
The project was partially funded by Ministero del Poder Popular para Ciencias y Tecnología
2022-MED-001
Escuela de Medicina, Universidad de Especialidades Espíritu Santo (UEES)
NLK
Directory of Open Access Journals
from 2009
Free Medical Journals
from 2009
PubMed Central
from 2004
Europe PubMed Central
from 2004
ProQuest Central
from 2004-01-01
Open Access Digital Library
from 2004-01-01
Open Access Digital Library
from 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2004
PubMed
38139835
DOI
10.3390/ph16121709
Knihovny.cz E-resources
- Publication type
- Journal Article MeSH
A series of heterocyclic chloroquine hybrids, containing a chain of two carbon atoms at position four of the quinolinic chain and acting as a link between quinoline and several benzoyl groups, is synthesized and screened in vitro as an inhibitor of β-hematin formation and in vivo for its antimalarial activity against chloroquine-sensitive strains of Plasmodium berghei ANKA in this study. The compounds significantly reduced haeme crystallization, with IC50 values < 10 μM. The values were comparable to chloroquine's, with an IC50 of 1.50 ± 0.01 μM. The compounds 4c and 4e prolonged the average survival time of the infected mice to 16.7 ± 2.16 and 14.4 ± 1.20 days, respectively. We also studied the effect of the compounds 4b, 4c, and 4e on another important human parasite, Leishmania mexicana, which is responsible for cutaneous leishmaniasis, demonstrating a potential leishmanicidal effect against promasigotes, with an IC50 < 10 μM. Concerning the possible mechanism of action of these compounds on Lesihmania mexicana, we performed experiments demonstrating that these three compounds could induce the collapse of the parasite mitochondrial electrochemical membrane potential (Δφ). The in vitro cytotoxicity assays against mammalian cancerous and noncancerous human cell lines showed that the studied compounds exhibit low cytotoxic effects. The ADME/Tox analysis predicted moderate lipophilicity values, low unbound fraction values, and a poor distribution for these compounds. Therefore, moderate bioavailability was expected. We calculated other molecular descriptors, such as the topological polar surface area, according to Veber's rules, and except for 2 and 4i, the rest of the compounds violated this descriptor, demonstrating the low antimalarial activity of our compounds in vivo.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23022335
- 003
- CZ-PrNML
- 005
- 20240116163015.0
- 007
- ta
- 008
- 240105s2023 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/ph16121709 $2 doi
- 035 __
- $a (PubMed)38139835
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Gutiérrez, Joyce E $u Organic Synthesis Laboratory, Faculty of Pharmacy, Central University of Venezuela, Los Chaguaramos 1041-A, Caracas 1040, Venezuela
- 245 10
- $a Synthesis, Antimalarial, Antileishmanial, and Cytotoxicity Activities and Preliminary In Silico ADMET Studies of 2-(7-Chloroquinolin-4-ylamino)ethyl Benzoate Derivatives / $c JE. Gutiérrez, H. Ramírez, E. Fernandez-Moreira, ME. Acosta, MR. Mijares, JB. De Sanctis, S. Gurská, P. Džubák, M. Hajdúch, L. Labrador-Fagúndez, BG. Stella, LJ. Díaz-Pérez, G. Benaim, JE. Charris
- 520 9_
- $a A series of heterocyclic chloroquine hybrids, containing a chain of two carbon atoms at position four of the quinolinic chain and acting as a link between quinoline and several benzoyl groups, is synthesized and screened in vitro as an inhibitor of β-hematin formation and in vivo for its antimalarial activity against chloroquine-sensitive strains of Plasmodium berghei ANKA in this study. The compounds significantly reduced haeme crystallization, with IC50 values < 10 μM. The values were comparable to chloroquine's, with an IC50 of 1.50 ± 0.01 μM. The compounds 4c and 4e prolonged the average survival time of the infected mice to 16.7 ± 2.16 and 14.4 ± 1.20 days, respectively. We also studied the effect of the compounds 4b, 4c, and 4e on another important human parasite, Leishmania mexicana, which is responsible for cutaneous leishmaniasis, demonstrating a potential leishmanicidal effect against promasigotes, with an IC50 < 10 μM. Concerning the possible mechanism of action of these compounds on Lesihmania mexicana, we performed experiments demonstrating that these three compounds could induce the collapse of the parasite mitochondrial electrochemical membrane potential (Δφ). The in vitro cytotoxicity assays against mammalian cancerous and noncancerous human cell lines showed that the studied compounds exhibit low cytotoxic effects. The ADME/Tox analysis predicted moderate lipophilicity values, low unbound fraction values, and a poor distribution for these compounds. Therefore, moderate bioavailability was expected. We calculated other molecular descriptors, such as the topological polar surface area, according to Veber's rules, and except for 2 and 4i, the rest of the compounds violated this descriptor, demonstrating the low antimalarial activity of our compounds in vivo.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Ramírez, Hegira $u Facultad de Ciencias de la Salud y Desarrollo Humano, Univesidad Ecotec, Km. 13.5 Samborondón, Guayas, Guayaquil 092302, Ecuador $1 https://orcid.org/0000000319166118
- 700 1_
- $a Fernandez-Moreira, Esteban $u Escuela de Medicina, Universidad Espíritu Santo, Samborondón, Guayas, Guayaquil 092301, Ecuador
- 700 1_
- $a Acosta, María E $u Unidad de Bioquímica, Facultad de Farmacia, Central University of Venezuela, Los Chaguaramos 1041-A, Caracas 1040, Venezuela
- 700 1_
- $a Mijares, Michael R $u Biotechnology Unit, Faculty of Pharmacy, Central University of Venezuela, Los Chaguaramos 1041-A, Caracas 1040, Venezuela $1 https://orcid.org/0000000200552804
- 700 1_
- $a De Sanctis, Juan Bautista $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Hněvotínská 1333/5, 779 00 Olomouc, Czech Republic $1 https://orcid.org/0000000254804608
- 700 1_
- $a Gurská, Soňa $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Hněvotínská 1333/5, 779 00 Olomouc, Czech Republic
- 700 1_
- $a Džubák, Petr $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Hněvotínská 1333/5, 779 00 Olomouc, Czech Republic $1 https://orcid.org/0000000230985969 $7 xx0080445
- 700 1_
- $a Hajdúch, Marián $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Hněvotínská 1333/5, 779 00 Olomouc, Czech Republic $1 https://orcid.org/000000024834908X $7 xx0050218
- 700 1_
- $a Labrador-Fagúndez, Liesangerli $u Unidad de Bioquímica de Parásitos y Señalización Celular, Instituto de Estudios Avanzados (IDEA), Caracas 1080, Venezuela $1 https://orcid.org/0009000422352469
- 700 1_
- $a Stella, Bruno G $u Unidad de Bioquímica de Parásitos y Señalización Celular, Instituto de Estudios Avanzados (IDEA), Caracas 1080, Venezuela $1 https://orcid.org/0009000189864694
- 700 1_
- $a Díaz-Pérez, Luis José $u Unidad de Bioquímica de Parásitos y Señalización Celular, Instituto de Estudios Avanzados (IDEA), Caracas 1080, Venezuela $1 https://orcid.org/0000000291977815
- 700 1_
- $a Benaim, Gustavo $u Unidad de Bioquímica de Parásitos y Señalización Celular, Instituto de Estudios Avanzados (IDEA), Caracas 1080, Venezuela $u Instituto de Biología Experimental, Facultad de Ciencias, Central University of Venezuela, Caracas 1040, Venezuela $1 https://orcid.org/0000000293595546
- 700 1_
- $a Charris, Jaime E $u Organic Synthesis Laboratory, Faculty of Pharmacy, Central University of Venezuela, Los Chaguaramos 1041-A, Caracas 1040, Venezuela $1 https://orcid.org/0000000344042619
- 773 0_
- $w MED00184066 $t Pharmaceuticals (Basel, Switzerland) $x 1424-8247 $g Roč. 16, č. 12 (2023)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38139835 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240105 $b ABA008
- 991 __
- $a 20240116163012 $b ABA008
- 999 __
- $a ok $b bmc $g 2036244 $s 1208780
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2023 $b 16 $c 12 $e 20231209 $i 1424-8247 $m Pharmaceuticals $n Pharmaceuticals (Basel) $x MED00184066
- GRA __
- $a 028/2022, 055/2023 $p The project was partially funded by Ministero del Poder Popular para Ciencias y Tecnología
- GRA __
- $a 2022-MED-001 $p Escuela de Medicina, Universidad de Especialidades Espíritu Santo (UEES)
- LZP __
- $a Pubmed-20240105